I. BACKGROUND

1. The Respondent was originally licensed to practice medicine in Maryland
on December 31,1987, under License Number D26182. The Respondent’s latest license
was given the expiration date of June 30, 2019.

2. The Respondent is currently employed as a physician at a health care
facility (“Facility A”)' in Greenbelt, Maryland, and performs physical examinations, pre-
operative evaluations and acts as a second surgeon assisting in its ambulatory surgical
center. For the past two years, the Respondent has also been employed at a health care
facility (“Facility B”) in Silver Spring, Maryland, working with weight loss patients. The
Respondent was previously employed at a health care facility (“Facility C”) as a locum
tenens physician from in or around April 2018 to in or around August 2018.

3. The Respondent is not board-certified in any medical specialty.

Il. THE COMPLAINT

4, The Board initiated an investigation of the Respondent after receiving a
complaint, dated July 18, 2018, from a pharmacy manager (the “Complainant”) of a
pharmacy located in Cambridge, Maryland. The Complainant reported that the pharmacy
had received an influx of prescriptions for oxycodone 30 mg,’ in quantities of 120 units
or greater, which were written/issued by the Respondent. The Complainant reported that
he was unable to contact the Respondent when questioning such prescribing. The
' For confidentiality reasons, the names/identities of medical facilities, Complainants, pharmacies, and

other individuals will not be disclosed in this document. The Respondent may obtain the identity of any
entity/individual referenced herein by contacting the assigned administrative prosecutor.

Oxycodone is an opioid analgesic and is a Schedule II controlled dangerous substance.
